Evidence-based practices for substance use disorders

Psychiatric Clinics of North America

Volumn 26, Issue 4, 2003, Pages 991-1010

  McGovern, Mark P ^a,b   Carroll, Kathleen M ^c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACAMPROSATE; ALCOHOL; ALDEHYDE DEHYDROGENASE; ANTICONVULSIVE AGENT; BUPRENORPHINE; CALCIUM CARBIMIDE; CANNABIS; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; COCAINE; DIAMORPHINE; DISULFIRAM; ILLICIT DRUG; KAPPA OPIATE RECEPTOR; LEVACETYLMETHADOL; LITHIUM; LONG ACTING DRUG; METHADONE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALTREXONE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; PLACEBO; SEROTONIN AGONIST; UNINDEXED DRUG;

ALCOHOLISM; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; EMPLOYMENT; EVALUATION; EVIDENCE BASED MEDICINE; FAMILY THERAPY; HEALTH PROGRAM; HUMAN; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; MENTAL HEALTH SERVICE; MOTIVATION; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOCIAL ASPECT; SUBSTANCE ABUSE; TECHNIQUE;

EID: 0347363895     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00073-X     Document Type: Review

References (137)

1. Sobell LC, Toneatto T, Sobell MC. Behavioral assessment and treatment planning for alcohol, tobacco, and other drug problems: current status with an emphasis on clinical applications. Behavior Therapy 1994;25:533-80.
2. McLellan AT, Lewis DC, O'Brien CP. Kleber HD. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. JAMA 2001:284:1689-95.
3. McLellan AT. McKay JR. The treatment of addiction: what can research offer practice? In: Lamb S. Greenlick M, McCarty D, editors. Bridging the gap between practice and research: forging partnerships with community based drug and alcohol treatment. Washington (DC): National Academy Press: 1998.
4. O'Brien CP. A range of research-based pharmacotherapies for addiction. Science 1997;278:66-70.
5. Rounsaville BJ, Kosten TR. Treatment for opioid dependence: quality and access. JAMA 2000;283(10):1337-9.
6. Simpson DD, Joe GW. Brown BS. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997;11:294-307.
7. American Psychiatric Association. Practice guidelines for the treatment of patients with nicotine dependence. Washington (DC): American Psychiatric Press; 1996.
8. Miller WR, Wilbourne PL. Mesa grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002;97:265-77.
9. Guyatt G, Haynes B, Jaeschke R, Cook D, Greenhalgh D, Meade M, et al. Introduction: the philosophy of evidence-based medicine. In: Guyatt G, Rennie D, editors. A manual for evidence-based clinical practice. Chicago: American Medical Association; 2002. p. 3-12.
10. Guyatt G, Rennie D, editors. A manual for evidence-based clinical practice. Chicago: American Medical Association; 2002.
11. McCrady BS. Alcohol use disorders and the Division 12 task force of the American Psychological Association. Psychol Addict Behav 2000;14:267-76.
12. Chambless DL, Sanderson WC, Shoham V, Johnson SB, Pope KS, Crits-Christoph P, et al. An update on empirically validated therapies. The Clinical Psycologist 1996;49:5-11.
13. Onken LS, Blaine JD, Battjes RJ., Behavioral therapy research: a conceptualization of a process. In: Henggeler SW, Santos AB, editors. Innovative approaches for difficult-to-treat populations. Washington (DC): American Psychiatric Press; 1997. p. 477-85.
14. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research. Clinical Psychology: Science and Practice 2001;8:133-42.
15. US Food and Drug Administration. Food and Drug Administration/Center for Drug Evaluation Research guidelines for the format and content of the clinical and statistical sections of the application. Washington, DC: DHHS; 1988.
16. US Food and Drug Administration. Center for Drug Evaluation Research. The CDER Handbook. Washington, DC; 1998.
17. Kazdin AE. Progression of therapy research and clinical application requires better understanding of the change process. Clinical Psychology: Science and Practice 2001;8:143-51.
18. Gonzales JJ, Ringeisen HL, Chambers DA. The tangled and thorny path of science to practice. Clinical Psychology: Science and Practice 2002;9:204-9.
19. O'Brien CP. Recent developments in the pharmacotherapy of substance abuse. J Consult Clin Psychol 1996;64:677-86.
20. Betz C, Hihalic D, Pinto ME, Raffa RB. Could a common biochemical mechanism underlie addictions?. J Clin Pharm Ther 2000;25:11-20.
21. Koob GF. Neurobiology of addiction. Ann N Y Acad Sci 2000;909:170-85.
22. Kreek MJ. Opiate and cocaine addiction. Pharmacol Biochem Behav 1997;57:551-69.
23. Kreek MJ, LaForge S, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002;1:710-26.
24. Sindelar JC, Fiellin DA. Innovations in treatment of drug abuse. Ann Rev Public Health 2001;22:249-72.
25. Swift RM, Drug therapy for alcohol dependence. N Engl J Med 1999;340:1482-90.
26. Fuller RK, Branchey L, Brightwell DR. Disulfiram treatment of alcoholics. JAMA 1986;256:1449-55.
27. Hughes JC, Cook CCH. The efficacy of disulfiram: a review of outcome studies. Addiction 1997;92:381-95.
28. Volpicelli JR, Alterman AI, Hayashida M, Obrien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psych 1992;49:876-80.
29. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld R, Meyer RE, Rounsaville BJ. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 1992;49:881-7.
30. O'Malley SS, Croop RS, Wroblewski JM, Labriola DF, Volpicelli JR. Naltrexone in the treatment of alcohol dependence. Psychiatr Annals 1995;25:681-8.
31. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R. Meyer RE, et al. Six month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996:53:217-24.
32. Addolorato G, Caputo F, Capristo E, Sefanini GF, Gasbarrini G. Gamma-hydroxybutyric acid: efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 2000;20:217-22.
33. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med 1966;118:304-9.
34. Kreek MJ, Vocci FJ. History and current status of opioid maintenance treatments. J Subs Abuse Treat 2002;23:93-105.
35. Raisch DW, Fye CL. Boardman KD, Sather MR. Opioid dependence treatment. Ann Pharmacother 2002;36:312-21.
36. Earlywine M. Understanding marijuana. New York: Oxford University Press; 2002.
37. Cacciola JS, Alterman AI, McKay JR, Rutherford MJ. Psychiatric comorbidity in patients with substance use disorders. Psychiatr Annals 2001;31:321-31.
38. Carroll KM. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. Psychology of Addictive Behaviors 1997:22:233-45.
39. O'Farrell TJ, Cutter HSG, Floyd FJ. Evaluating behavioral marital therapy for male alcoholics. Behav Ther 1985;15:147-68.
40. Fals-Stewart W, O'Farrell TJ, Birchler GR. Behavioral couples therapy for male methadone maintenance patients. Behav Ther 2001;32:391-411.
41. O'Farrell TJ, Fals-Stewart W. Behavioral couples therapy for alcohol and drug abuse. J Subs Abuse Treat 2000;18:51-4.
42. O'Farrell TJ, Fals-Stewart W. Behavioral couples and family therapy with substance abusers. Curr Psychiatry Rep 2002;4:371-6.
43. Fals-Stewart W, O'Farrell TJ, Birchler GR. Behavioral couples therapy for male substance abusing patients: a cost outcomes analysis. J Consult Clin Psychol 1997;65:789-802.
44. O'Farrell TJ, Cutter HS, Choquette KA, Floyd FJ. Behavioral marital therapy for male alcoholics: marital and drinking adjustment during 2 years after treatment. Behav Ther 1992;23:529-49.
45. Babor TF, Grant M. Project on identification and management of alcohol-related problems. Report on Phase II. A randomized clinical trial of brief interventions in primary health care. Geneva Switzerland: World Health Organization; 1992.
46. Fleming MF, Bouny KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community based primary care practices. JAMA 1997;277:1039-45.
47. Friedman PDD, McCullough D. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med 2001;161:248-51.
48. Sullivan E, Fleming MF. A guide to substance abuse services for primary care physicians. 1997; Rockville MD: Center for Substance Abuse Treatment, DHHS. Tip #24
49. Santisteban DA, Szapocznik J, Perez-Vidal A, Kurtines WM, Murray EJ, Laperriere A. Efficacy of intervention for engaging youth and families into treatment and some variables that may contribute to differential effectiveness. J Fam Psychol 1996;10:35-44.
50. Szapocznik J, Perez-Vidal A, Brickman RL, Foote FH, Santisteban DA, Hervis O. et al. Engaging adolescent drug abusers and their families in treatment: a strategic structural systems approach. J Consult Clin Psychol 1998;56:552-7.
51. Szapocznik J, Kurtines WM, Foote FH, Perez-Vidal A, Hervis O. Conjoint versus one-person family therapy. J Consult Clin Psychol 1996;54:395-7.
52. Carroll KM. Behavioral and cognitive behavioral treatments. In: McCrady BS, EE Epstein EE, editors. Addictions: a Comprehensive Guidebook. New York: Oxford University Press; 1999. p. 250-67.
53. Irvin JE, Bowers CA, Dunn ME, Wong MC. Efficacy of relapse prevention: a metaanalytic review. J Consult Clin Psychol 1999;67:563-70.
54. Project MATCH Research Group. Matching alcohol treatments to client heterogeneity: Project MATCH post-treatment drinking outcomes. J Stud Alcohol 1997;58:7-29.
55. Siqueland L, Crits-Christoph P. Current developments in psychosocial treatments of alcohol and substance abuse. Curr Psychiatry Rep 1999;1:179-84.
56. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin FH. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994:51:989-97.
57. McKay JR, Alterman AI, Cacciola JS, O'Brien CP. Koppenhaver J, Shepard DS. Continuing care for cocaine dependence: comprehensive 2-year outcomes. J Consult Clin Psychol 1999;63:70-8.
58. Rawson RA, Huber A. McCann MJ, Shoptaw S, Farabee D, Reiber C. et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Arch Gen Psychiatry 2002;59:817-24.
59. Carroll KM, Rounsaville BJ, Gawin FH. A comparative trial of psychotherapies for ambulatory cocaine abusers. American Journal of Drug and Alcohol Dependence 1996;17:229-47.
60. Monti PM, Abrams DB, Binkof JA, Zwick WR, Liepman MR, Nirenberg TD, et al. Communication skills training with family and cognitive-behavioral mood management training for alcoholics. J Stud Alcohol 1990;51:263-70.
61. Kadden R, Carroll KM, Donovan D, Cooney N, Monti P, Abrams D, et al. Cognitive-behavioral coping skills therapy manual. Rockville MD: NIAAA, DHHS; 1999.
62. Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford; 1985.
63. Higgins ST. Budney AJ. Bickel WK, Hughes JR, Foerg FE, Badger GJ. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993;150:763-9.
64. Higgins ST. Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994;51:568-76.
65. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year follow-up. J Consult Clin Psychol 2000;68:64-72.
66. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996;53:409-15.
67. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, et al. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 1996:41:157-65.
68. Silverman K, Wong CJ, Unbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. JCCP 1998;66:811-24.
69. Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000;68:250-7.
70. Petry NM, Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002;70:398-405.
71. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000;68:1051-61.
72. Daley DC, Mercer D, Carpenter G. Drug counseling for cocaine addiction: the Collaborative Cocaine Treatment Study Model. Bethesda MD: NIDA; 2002.
73. Mercer DE, Woody GE. An individual drug counseling approach to treat cocaine Addiction: the Collaborative Cocaine Treatment Study Model. Rockville (MD): NIDA; 1999.
74. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Psychotherapy in community-based methadone programs. Am J Psychol 1995;152:1302-8.
75. Crits-Christoph P, Siqueland L, Blaine J. Psychosocial treatments for cocaine dependence. Arch Gen Psychiatry 1999;59:503-12.
76. Miller WR, Rollnick S. Motivational interviewing. New York: Guilford; 1991.
77. Prochaska JO, DiClemente CC. Toward a comprehensive model of change. In: Miller WR, Heather N, editors. Treating addictive behaviors. New York: Plenum; 1986. p. 3-27.
78. Miller WR, Benefield RG, Tonigan JS. Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles. J Cons Clin Psych 1993;61:455-61.
79. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH 3-year drinking outcomes. Alcohol Clin Exp Res 1998;22:1300-11.
80. Marlatt GA, Baer JS, Kivlahan DR, Dimeff LA. Larimer ME, Quigley LA, et al. Screening and brief intervention for high-risk college student drinkers: results from a 2-year follow-up assessment. J Consult Clin Psychol 1998;66:604-15.
81. Karey KB, Purnine DM, Maisto SA, Karey MP. Enhancing readiness-to-change substance abuse in persons with schizophrenia. Behav Modif 2001;25:331-84.
82. Sampl S, Kadden R. Motivational enhancement therapy and cognitive behavioral therapy (MET-CBT-5) for adolescent cannabis users. Rockville MD: Center for Substance Abuse Treatment, DHHS; 2001.
83. Dunn C, Deroo I, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001;96:1725-42.
84. Miller WR, Brown JM, Simpson TL, Handmaker NS, Bien TH, Luckie LF, et al. What works'? A methodological analysis of the alcohol treatment literature. In: Hester RK, Miller WR, editors. Handbook of alcoholism treatment approaches: effective alternatives. Boston: Allyn & Bacon; 1995. p. 12-44.
85. Wilk Al, Jensen NM, Havighurst TC. Meta-analysis of randomized controlled trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med 1997;12:274-83.
86. Liddle HA. Theory development in a family-based therapy for adolescent drug abuse. Clinical Child Psychology and Psychiatry 1999;28:521-32.
87. Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett KA, Tejeda M. Multi-dimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. American Journal of Drug and Alcohol Dependence 2001;27:651-87.
88. Diamond G, Godley SH, Liddle HA, Sampl S, Webb S, Tims FM, et al. Five outpatient treatment models for adolescent marijuana use. Addiction 2002;97:70-83.
89. Luborsky L. Principles of psychoanalytic psychotherapy: a manual for supportive-expressive psychotherapy. New York: Basic Books; 1984.
90. Woody GE, Luborsky L, McLellan AT. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 1983;40:639-45.
91. Nowinski J, Baker S, Carroll KM, Twelve-step facilitation therapy manual. Rockville (MD): NIAAA, DHHS; 1999.
92. Alcoholics Anonymous. Alcoholics anonymous. 3rd edition. New York: Alcoholics Anonymous World Services, Inc.: 1976.
93. Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998;93:13-27.
94. Carroll KM, Nich C, Ball SA, McCance-Katz EF, Frankforter TF, Rounsaville BJ. One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers. Addiction 2000;95:1335-49.
95. Carroll KM. Integrating psychotherapy with pharmacotherapy to improve drug abuse outcomes. Addict Behav 1997;22:233-45.
96. Miller NS, Smith DE. The integration of pharmacotherapy and nonpharmacotherapy. J Addict Dis 1997;16:51-64.
97. Boyarsky BK, McCance-Katz EF. Improving the quality of substance dependency treatment with pharmacotherapy. Subst Use Misuse 2000;35:2095-125.
98. Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York: Oxford University Press; 1990.
99. Simpson DD, Sells SB. Opioid addiction and treatment: a 12-year follow-up. Malabar (FL): Krieger; 1990.
100. McKay JR, Weiss RV. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Eval Rev 2001;25:113-61.
101. Simpson DD. Treatment for drug abuse. Arch Gen Psychiatry 1981;38:875-80.
102. Simpson DD, Joe GW, Bracy SA. Six-year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry 1982;39:1318-23.
103. McLellan AT, Grissom GR, Brill P, Durell J, Metzger DS, O'Brien CP. Private substance abuse treatment: are some programs more effective than others? J Subst Abuse Treat 1993;10:243-54.
104. McLellan AT, Grissom GR, Randall M, Brill P, O'Brien CP. Problem-service matching in addiction treatment. Arch Gen Psychiatry 1997;54:730-5.
105. McLellan AT, Hagan TA, Levine M, Gould F, Meyers K, Bencivengo M, et al. Supplemental social services improve outcomes in public addiction treatment. Addiction 1998;93:1489-99.
106. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K. Kola L, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;52:469-76.
107. McGovern MP, Angres DH, Leon S. Differential therapeutics and the impaired physician. J Addict Dis 1998;17:93-107.
108. Carroll KM. Implications of recent research for program quality in cocaine dependence treatment. Subst Use Misuse 2000;35:2011-30.
109. American Society of Addiction Medicine. American Society of Addiction Medicine patient placement criteria for the treatment of substance-related disorders. 2nd edition. Chevy Chase (MD): American Society of Addiction Medicine; 2001.
110. National Institute on Drug Abuse. Principles of drug addiction treatment. Rockville (MD): NIDA, DHHS; 2000.
111. Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction 1994;89:679-88.
112. Project MATCH Research Group. Therapist effects. Psychotherapy Research 1998;8:455-74.
113. Siqueland L, Crits-Christoph P, Barber J, Butler SF, Thase M, Najavits LM, et al. The role of therapist characteristics on training effects. J Psychother Pract Res 2000;9:123-30.
114. Rounsaville BJ, Carroll KM. Individual psychotherapy for drug abusers. In: Lowinsohn JH, Ruiz P, Miller RB, editors. Comprehensive textbook of substance abuse. New York: Williams & Wilkins; 1997. p. 430-9.
115. Nathan PE, McCrady BS. What makes treatment effective: treatment factors. Presented at the 110th Annual Conference of the American Psychological Association. Chicago, August 23, 2002.
116. Lamb S, Greenlick MR, McCarty D. Bridging the gap between practice and research. Washington (DC): National Academy Press; 1998.
117. McLellan AT. Technology transfer in the treatment of addiction. J Subst Abuse Treat 2002;22:169-70.
118. Hansen GR, Leshner Al, Tai B. Putting drug abuse research to use in real-life settings. J Subst Abuse Treat 2002;23:69-70.
119. Simpson DD. A conceptual framework for transferring research to practice. J Subst Abuse Treat 2002;22:171-82.
120. Roman PM, Johnson JA. Adoption and implementation of new technologies in substance abuse treatment. J Subst Abuse Treat 2002;22:211-8.
121. Klein KJ, Sorra JS. The challenge of implementation. Acad Manage Rev 1996;21:1055-80.
122. Robbins MS, Bachrach K, Szapocznik J. Bridging the research-practice gap in adolescent substance abuse treatment. J Subst Abuse Treat 2002;23:123-32.
123. Morgenstern J, Morgan TS, McCrady BS, Keller DS, Carroll KM. Manual-guided cognitive behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments into practice into the community. Psychol Addict Behav 2001;15:83-8.
124. Andrezejewski ME, Kirby KC, Morral AR, Iguchi MY. Technology transfer through performance management. Drug Alc Dep 2001;63:179-86.
125. Petry NM, Simic F. Recent advances in the dissemination of contingency management techniques. J Subs Abuse Treat 2002;23:81-6.
126. Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, et al. MET meets the real world. J Subs Abuse Treat 2002:23:73-80.
127. Carroll KM, Nich C, Sifry RL, Nuro KF, Frankforter TL, Ball SA, et al. A general system for evaluating therapist adherence and competence in psychotherapy. Drug Alcohol Depend 2000;57:225-38.
128. Miller WR, Mount KA. A small study of training in motivational interviewing: Does one workshop change clinician and client behavior? Behavioral and Cognitive Psychotherapy 2001;29:457-71.
129. Carroll KM, Rounsaville BJ. Bridging the gap between research and practice in substance abuse treatment. Psychiatr Serv 2003;54:333-9.
130. Forman RF, Bovasso G, Woody GE. Staff beliefs about addiction treatment. J Subst Abuse Treat 2001;21:1-9.
131. Ball SA, Bachrach K, DeCarlo J, Farentinos C, Keen M, McSherry T, et al. Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers. J Subst Abuse Treat 2002;23:309-18.
132. Godley SH, White WL, Diamond G, Passetti L, Titus JC. Therapist reactions to manual-guided therapies in the treatment of adolescent marijuana users. Clinical Psychology: Science and Practice 2001;8:405-17.
133. Carey KB, Purnine DM, Maisto SA, Carey MP, Simons JS. Treating substance abuse in the context of severe and persistent mental illness: clinicians' perspectives. J Subst Abuse Treat 2000;19:189-98.
134. Fals-Stewart W, Birchler GR. A national survey of the use of couples therapy in substance abuse treatment. J Subst Abuse Treat 2001;20:277-83.
135. Backer TE. Assessing and enhancing readiness for change: implications for technology transfer. In: Backer TE, Soucy G, editors. Reviewing the behavioral science knowledge base on technology transfer. Rockville (MD): NIDA, DHHS; 1995. p. 21-41.
136. Lehman WEK, Greener JM, Simpson DD. Assessing organizational readiness for change. J Subst Abuse Treat 2002;22:197-209.
137. Drake RE, Goldman HH, Leff HS, Lehman AF, Dixon L, Mueser KT, et al. Implementing evidence-based practices in routine mental health service settings. Psychiatr Serv 2001;52:179-82.